Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-000708-18Phase 3Completed
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD) comparing Ivabradine with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-000708-18.